|
Market Closed -
Toronto S.E.
18:45:35 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1050 CAD | 0.00% |
|
+10.53% | +5.00% |
| 08-14 | Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-26 | Resverlogix Corp. - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 26.02M | - | - | - | - | - |
| 70.07B | |||||
| 52.87B | |||||
| 27.02B | - | ||||
| 23.61B | |||||
| 23.38B | - |
- Stock Market
- Stocks
- RVX Stock
- Charts Resverlogix Corp.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
